Upcoming Biologics conference
3rd Global Biologics India 2026
22-23 April 2026
Hotel Le Meridien, Hyderabad, India

We intend to address various aspects within the broad field of biologics (Mabs, Vaccines and cell and Gene Therapy) including a focus on making biologics manufacturing processes more affordable, efficient and compliant with regulatory requirements.

Cell line Engineering for mABs

Process Development

Potential and challenges of Cell and Gene Therapy

Allogenic model for cell therapy- possible ways forward

GMP production of Gene Therapy biologics

Cost reduction – proven approaches that work

Group discussion – how to get high protein titer while managing the quality of protein

Facility design

CAR T cells , NK cells

New phase of stem cells and iPSCs

Challenges in meeting regulatory requirements for large molecule/biosimilars

Start ups- New future and hope

and many more…

Become aware of the challenges in regulatory approval for biologics and how to overcome them

Case studies on protein quality and yield optimization for MAbs

Process development and scale up challenges and solutions

Cell therapy – distinct development and big steps by Indian companies

Latest on tech transfer and QC on biologics, including cell therapy products

Get to meet and have 1 to 1 discussion with industry leaders and scientists actively working in the field today

Scientists (R&D, Process development and manufacturing) from Biotech companies (Vaccine, MAb and Cell Therapy fields)
Researchers from life sciences research institutes
Companies exploring markets for their products in India
Companies trying to increase market share in India
Venture Capitalist/Private Equity investigating investment opportunities in India
Regulatory and Quality Control professionals
Distributors of various solutions companies.
Any other person/company willing to gain more information on Indian Biotech landscape